• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 WITH SHUNTASSISTANT 25; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 WITH SHUNTASSISTANT 25; HYDROCEPHALUS VALVES Back to Search Results
Model Number FX414T
Device Problem Obstruction of Flow (2423)
Patient Problem Failure of Implant (1924)
Event Date 10/05/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional to the company sales representative "3m po valve is blocked.Explanted.".
 
Manufacturer Narrative
The shunt system was received submerged in an unidentified liquid in a plastic container.No deformation or damage of the valves were detected during the visual inspection.The permeability test has indicated that both the progav 2.0 valve and the shunt assistant are permeable.However, the shunt assistant drained slower than expected, indicating a partial blockage.Both valves discharged bloody fluid during the test.The progav 2.0 valve was tested and is adjustable to all specified pressures.The brake functionally test has shown that the brake function is fully operational and the braking force is with the given tolerances.We performed a visual inspection of the progav2.0 shunt system.No deformation or damage of the valves were detected during the visual inspection.Next we tested the permeability of the valves.The progav 2.0 valve was shown to be permeable.The shunt assistant, while permeable drained slowly indication a partial blockage.Additionally, we tested the adjustability as well as the brake functionality and brake force of the progav 2.0 valve.The valve operated as expected and met all specifications.Finally, we have dismantled the valve.Inside the progav2.0 valve we have found a buildup of bloody substance likely protein.Additionally, we observed slight deposits within the shunt assistant.Based on our investigation, we confirm the presence of occlusion in the shunt system, likely due to the deposits observed in both valves.We can exclude a defect at the time of release.The valve met all specifications of the final inspections.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 WITH SHUNTASSISTANT 25
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8053414
MDR Text Key126630131
Report Number3004721439-2018-00268
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/18/2023
Device Model NumberFX414T
Device Catalogue NumberFX414T
Device Lot Number20037612
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/10/2018
Distributor Facility Aware Date11/26/2018
Device Age7 MO
Date Manufacturer Received11/26/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age1 YR
Patient Weight7
-
-